Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.

<h4>Background</h4>Neglected tropical diseases, including diseases caused by trypanosomatid parasites such as Trypanosoma brucei, cost tens of millions of disability-adjusted life-years annually. As the current treatments for African trypanosomiasis and other similar infections are limit...

Full description

Saved in:
Bibliographic Details
Main Authors: Jacob D Durrant, Laurence Hall, Robert V Swift, Melissa Landon, Achim Schnaufer, Rommie E Amaro
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2010-08-01
Series:PLoS Neglected Tropical Diseases
Online Access:https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000803&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849694727489716224
author Jacob D Durrant
Laurence Hall
Robert V Swift
Melissa Landon
Achim Schnaufer
Rommie E Amaro
author_facet Jacob D Durrant
Laurence Hall
Robert V Swift
Melissa Landon
Achim Schnaufer
Rommie E Amaro
author_sort Jacob D Durrant
collection DOAJ
description <h4>Background</h4>Neglected tropical diseases, including diseases caused by trypanosomatid parasites such as Trypanosoma brucei, cost tens of millions of disability-adjusted life-years annually. As the current treatments for African trypanosomiasis and other similar infections are limited, new therapeutics are urgently needed. RNA Editing Ligase 1 (REL1), a protein unique to trypanosomes and other kinetoplastids, was identified recently as a potential drug target.<h4>Methodology/principal findings</h4>Motivated by the urgent need for novel trypanocidal therapeutics, we use an ensemble-based virtual-screening approach to discover new naphthalene-based TbREL1 inhibitors. The predicted binding modes of the active compounds are evaluated within the context of the flexible receptor model and combined with computational fragment mapping to determine the most likely binding mechanisms. Ultimately, four new low-micromolar inhibitors are presented. Three of the four compounds may bind to a newly revealed cleft that represents a putative druggable site not evident in any crystal structure.<h4>Conclusions/significance</h4>Pending additional optimization, the compounds presented here may serve as precursors for future novel therapies useful in the fight against several trypanosomatid pathogens, including human African trypanosomiasis, a devastating disease that afflicts the vulnerable patient populations of sub-Saharan Africa.
format Article
id doaj-art-c3492418d00d4e61bd981a818f9cd3e3
institution DOAJ
issn 1935-2727
1935-2735
language English
publishDate 2010-08-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Neglected Tropical Diseases
spelling doaj-art-c3492418d00d4e61bd981a818f9cd3e32025-08-20T03:19:59ZengPublic Library of Science (PLoS)PLoS Neglected Tropical Diseases1935-27271935-27352010-08-0148e80310.1371/journal.pntd.0000803Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.Jacob D DurrantLaurence HallRobert V SwiftMelissa LandonAchim SchnauferRommie E Amaro<h4>Background</h4>Neglected tropical diseases, including diseases caused by trypanosomatid parasites such as Trypanosoma brucei, cost tens of millions of disability-adjusted life-years annually. As the current treatments for African trypanosomiasis and other similar infections are limited, new therapeutics are urgently needed. RNA Editing Ligase 1 (REL1), a protein unique to trypanosomes and other kinetoplastids, was identified recently as a potential drug target.<h4>Methodology/principal findings</h4>Motivated by the urgent need for novel trypanocidal therapeutics, we use an ensemble-based virtual-screening approach to discover new naphthalene-based TbREL1 inhibitors. The predicted binding modes of the active compounds are evaluated within the context of the flexible receptor model and combined with computational fragment mapping to determine the most likely binding mechanisms. Ultimately, four new low-micromolar inhibitors are presented. Three of the four compounds may bind to a newly revealed cleft that represents a putative druggable site not evident in any crystal structure.<h4>Conclusions/significance</h4>Pending additional optimization, the compounds presented here may serve as precursors for future novel therapies useful in the fight against several trypanosomatid pathogens, including human African trypanosomiasis, a devastating disease that afflicts the vulnerable patient populations of sub-Saharan Africa.https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000803&type=printable
spellingShingle Jacob D Durrant
Laurence Hall
Robert V Swift
Melissa Landon
Achim Schnaufer
Rommie E Amaro
Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
PLoS Neglected Tropical Diseases
title Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
title_full Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
title_fullStr Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
title_full_unstemmed Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
title_short Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.
title_sort novel naphthalene based inhibitors of trypanosoma brucei rna editing ligase 1
url https://journals.plos.org/plosntds/article/file?id=10.1371/journal.pntd.0000803&type=printable
work_keys_str_mv AT jacobddurrant novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1
AT laurencehall novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1
AT robertvswift novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1
AT melissalandon novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1
AT achimschnaufer novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1
AT rommieeamaro novelnaphthalenebasedinhibitorsoftrypanosomabruceirnaeditingligase1